Kadia Siddhartha 4/A

What Happened
Kadia Siddhartha, President and CEO of Mesa Laboratories, received a grant of 35,236 restricted stock units (RSUs) on April 14, 2026. The award is reported as a derivative award with an acquisition price of $0.00 (typical for RSU grants); no cash was exchanged at grant. The RSUs represent contingent rights to receive one share each if and when they vest.

Key Details

• Transaction date: 2026-04-14; transaction type: Award/Grant (code A).
• Shares/units granted: 35,236 RSUs; reported price: $0.00 per unit (derivative award).
• Shares owned after transaction: not disclosed in the provided filing excerpt.
• Footnotes: F1 — each RSU converts to one share if vested; F2 — RSUs vest 1/3 on each anniversary (three‑year vesting); F3 — Not applicable.
• Filing status: This is an amended Form 4 (filed 2026-05-19), indicating the original report was revised or corrected.

Context
RSUs are a form of compensation, not an open‑market purchase or sale—value is realized only when units vest and convert to shares, and then depends on the stock price at that time. This grant is routine executive compensation and does not by itself indicate the CEO bought or sold shares in the market.